JP2022552892A5 - - Google Patents

Info

Publication number
JP2022552892A5
JP2022552892A5 JP2022523659A JP2022523659A JP2022552892A5 JP 2022552892 A5 JP2022552892 A5 JP 2022552892A5 JP 2022523659 A JP2022523659 A JP 2022523659A JP 2022523659 A JP2022523659 A JP 2022523659A JP 2022552892 A5 JP2022552892 A5 JP 2022552892A5
Authority
JP
Japan
Prior art keywords
seq
acid sequence
nucleic acid
aav3b
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022523659A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022552892A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/056511 external-priority patent/WO2021080991A1/en
Publication of JP2022552892A publication Critical patent/JP2022552892A/ja
Publication of JP2022552892A5 publication Critical patent/JP2022552892A5/ja
Pending legal-status Critical Current

Links

JP2022523659A 2019-10-21 2020-10-20 改善された産生収率および肝臓向性を有するaav3b変異体 Pending JP2022552892A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962924112P 2019-10-21 2019-10-21
US62/924,112 2019-10-21
US202063025753P 2020-05-15 2020-05-15
US63/025,753 2020-05-15
PCT/US2020/056511 WO2021080991A1 (en) 2019-10-21 2020-10-20 Aav3b variants with improved production yield and liver tropism

Publications (2)

Publication Number Publication Date
JP2022552892A JP2022552892A (ja) 2022-12-20
JP2022552892A5 true JP2022552892A5 (enExample) 2023-10-18

Family

ID=75620806

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022523659A Pending JP2022552892A (ja) 2019-10-21 2020-10-20 改善された産生収率および肝臓向性を有するaav3b変異体

Country Status (7)

Country Link
US (1) US20230002788A1 (enExample)
EP (1) EP4048681A4 (enExample)
JP (1) JP2022552892A (enExample)
AU (1) AU2020369508A1 (enExample)
CA (1) CA3155016A1 (enExample)
TW (1) TW202130653A (enExample)
WO (1) WO2021080991A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113444785B (zh) * 2021-06-28 2022-06-21 甘肃农业大学 一种与仔猪C型产气荚膜梭菌感染性腹泻相关的ssc-miR-122-5p及其应用
WO2023049846A1 (en) * 2021-09-24 2023-03-30 The Trustees Of The University Of Pennsylvania Compositions useful for treatment of charcot-marie-tooth disease
WO2023196892A1 (en) 2022-04-06 2023-10-12 The Trustees Of The University Of Pennsylvania Passive immunization with anti- aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156303A (en) * 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
US7749492B2 (en) * 2001-01-05 2010-07-06 Nationwide Children's Hospital, Inc. AAV vectors and methods
CN107073051B (zh) * 2014-10-21 2021-08-24 马萨诸塞大学 重组aav变体及其用途
US10081659B2 (en) * 2015-04-06 2018-09-25 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Adeno-associated vectors for enhanced transduction and reduced immunogenicity
US11364308B2 (en) * 2016-05-13 2022-06-21 4D Molecular Therapeutics Inc. Adeno-associated virus variant capsids and methods of use thereof
EP3585900B1 (en) * 2017-02-22 2022-12-21 CRISPR Therapeutics AG Materials and methods for treatment of spinocerebellar ataxia type 2 (sca2) and other spinocerebellar ataxia type 2 protein (atxn2) gene related conditions or disorders
WO2018200419A1 (en) * 2017-04-23 2018-11-01 The Trustees Of The University Of Pennsylvania Viral vectors comprising engineered aav capsids and compositions containing the same
EP3768695A4 (en) * 2018-02-27 2022-04-06 The Trustees of the University of Pennsylvania NOVEL ADENO-ASSOCIATED VIRUS (AAV) VECTORS, AAV VECTORS WITH REDUCED CAPSIID DEAMIDATION AND USES THEREOF
IL276859B2 (en) * 2018-02-27 2025-12-01 Univ Pennsylvania Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor

Similar Documents

Publication Publication Date Title
JP2022530633A5 (enExample)
JP2022530656A5 (enExample)
JP2022530544A5 (enExample)
JP2018108113A5 (enExample)
AU2020204679B2 (en) Gene therapy constructs for treating wilson disease
FI3684423T3 (fi) Adenoassesioidun viruksen kapsidivariantteja ja niiden käyttömenetelmiä
CN109715650B (zh) 新颖腺相关病毒衣壳蛋白
JP2024045227A (ja) パルボウイルスベクターの高められた送達のための改変キャプシドタンパク質
JP6619454B2 (ja) キャプシド
JP2022078208A5 (enExample)
US6365403B1 (en) High-efficiency AAV helper functions
JP2021515548A5 (enExample)
JP2022033245A5 (enExample)
JP2023537625A5 (enExample)
JP2024514956A (ja) 組織標的化された改変aavカプシドおよびその使用方法
JP2020528734A5 (enExample)
JP2023550581A5 (enExample)
KR20180091863A (ko) 임상적 사용에 적합한 무혈청 현탁 세포 배양 시스템에서 재조합 아데노-관련 바이러스(aav) 벡터를 생성하기 위한 확장가능한 방법
JP2022531861A5 (enExample)
KR20160033217A (ko) 변종 aav 및 조성물, 세포, 기관 및 조직으로의 유전자 전이를 위한 방법 및 용도
CA2469053A1 (en) Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
TW201629225A (zh) 第九因子基因療法
JP2011101646A5 (enExample)
JP2022552892A5 (enExample)
JP2017529395A5 (enExample)